Navigating the Challenges of Bispecific Antibody Development Through a Unified Approach
Explore the Integrated Development Approach
The pharmaceutical industry is continuously evolving, with innovative modalities such as bispecific antibodies gaining traction. However, the complexity of these biotherapeutics introduces significant development challenges that require a strategic approach to mitigate associated risks.
Xtalks recently announced a free webinar, titled **